Stereotaxis, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $32.4M | $26.9M | $26.8M | $28.1M | $35.0M |
| Cost of revenue | $15.3M | $12.3M | $11.9M | $9.7M | $11.8M |
| Gross profit | $17.1M | $14.6M | $14.9M | $18.5M | $23.2M |
| Research and development | $9.4M | $9.8M | $10.3M | $10.6M | $10.2M |
| Operating expenses | $39.2M | $39.3M | $36.7M | $37.2M | $36.1M |
| Operating income | -$22.1M | -$24.7M | -$21.8M | -$18.8M | -$12.9M |
| Net income | -$21.6M | -$24.0M | -$20.7M | -$18.3M | -$10.7M |
| Balance Sheet | |||||
| Cash and equivalents | $13.4M | $12.2M | $19.8M | $8.6M | $38.7M |
| Current assets | $33.8M | $26.4M | $33.3M | $43.2M | $51.4M |
| Total assets | $52.3M | $46.7M | $41.9M | $53.4M | $61.0M |
| Current liabilities | $22.4M | $21.6M | $13.2M | $14.3M | $13.3M |
| Total liabilities | $33.5M | $35.3M | $20.0M | $21.5M | $21.6M |
| Stockholders' equity | $13.5M | $6.1M | $16.3M | $26.3M | $33.8M |
| Cash Flow Statement | |||||
| Cash from operations | -$13.7M | -$8.5M | -$9.1M | -$8.4M | -$2.9M |
| Depreciation and amortization | $626,000 | $587,000 | $595,000 | $429,000 | $106,000 |
| Stock-based compensation | $9.9M | $10.3M | $10.6M | $10.6M | $9.4M |
| Capital expenditure | $93,000 | $34,000 | $366,000 | $2.4M | $1.4M |
| Free cash flow | -$13.8M | -$8.5M | -$9.5M | -$10.8M | -$4.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 97.7M · Free float 56.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.